Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 12/20 | 0.38 |
| ▸ | ACHE | P22303 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL23356582 | 0.76 | MEN1 (0.38) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL320422 | 0.76 | HDAC8 (0.62) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL31105615 | 0.76 | HDAC8 (0.62) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL20495381 | 0.74 | GPR3 (0.38) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL578286 | 0.73 | KDM4E (0.38) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL3855070 | 0.72 | KCNH2 (0.43) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL20495457 | 0.72 | GPR3 (0.39) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL7077338 | 0.71 | GPR3 (0.41) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL31683143 | 0.71 | GPR3 (0.41) | GPR3KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL20495508 | 0.70 | KDM4E (0.45) | GPR3KCNH2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | GPR3 4248/4885KCNH2 1920/4885ACHE 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.